US 10912792
Compounds and methods for modulating angiotensinogen expression
granted A61KA61K31/712A61P
Quick answer
US patent 10912792 (Compounds and methods for modulating angiotensinogen expression) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/712, A61P, A61P9/12